These relationships and recognitions reflect where our work intersects with real-world program complexity, executive decision-making, and industry-wide impact.
Virtue 340B’s work is grounded in independent oversight, but validated through partnerships, recognition, and engagement across the healthcare and pharmacy ecosystem. Our work within the 340B Drug Pricing Program has been recognized through multiple industry awards and strategic partnerships that reflect our commitment to compliance excellence.
Virtue 340B partners with GCA 340B to provide independent audit and risk oversight within vendor-managed 340B environments.
GCA 340B delivers operational program management across complex 340B programs, while Virtue 340B provides an independent layer of review designed to identify hidden exposure, validate program integrity, and strengthen audit readiness.
This structure allows organizations to benefit from both operational execution and independent oversight—without conflict.
As reflected in GCA 340B’s partnership narrative, this model enables healthcare organizations to proactively prepare for HRSA-level audit scrutiny, strengthening both compliance readiness and leadership confidence.
HANYS Marketplace — Healthcare Association Partnership
Virtue 340B is a selected partner of HANYS Marketplace®, connecting New York hospitals and health systems with independent 340B oversight and advisory support.
HANYS Marketplace curates vetted solutions for healthcare providers, ensuring access to trusted partners aligned with operational and governance priorities.
“Virtue 340B provides independent, high-integrity oversight that helps New York’s hospitals and health systems strengthen governance and protect the durability of their 340B programs.”
RXinsider Pharmacy500 & Industry Platform Presence
Virtue 340B has been recognized as a Pharmacy500 company by RXinsider, reflecting measurable impact on pharmacy operations and the broader supply chain ecosystem.
The Pharmacy500 recognizes organizations that have significantly influenced dispensing pharmacy performance across the United States.
RXinsider itself serves as a pharmacy-focused market intelligence and communications platform, providing resources, publications, and insights to pharmacy leadership and operational stakeholders.
Through this platform, Virtue maintains visibility within the pharmacy ecosystem—engaging decision-makers and contributing to industry-wide understanding of 340B risk and oversight.
New York State Certified Minority Business Enterprise (MBE)
This certification confirms verified ownership, control, and operational independence—reinforcing Virtue’s structure as an independent advisory firm without vendor conflicts or external influence.
